NYNOMIC AG (M7U.DE) Fundamental Analysis & Valuation

FRA:M7U • DE000A0MSN11

Current stock price

18.9 EUR
+1.15 (+6.48%)
Last:

This M7U.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. M7U.DE Profitability Analysis

1.1 Basic Checks

  • M7U had negative earnings in the past year.
  • In the past year M7U had a positive cash flow from operations.
  • Of the past 5 years M7U 4 years were profitable.
  • In the past 5 years M7U always reported a positive cash flow from operatings.
M7U.DE Yearly Net Income VS EBIT VS OCF VS FCFM7U.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

  • M7U has a worse Return On Assets (-5.07%) than 74.07% of its industry peers.
  • M7U has a Return On Equity of -7.06%. This is in the lower half of the industry: M7U underperforms 68.52% of its industry peers.
  • With a Return On Invested Capital value of 0.70%, M7U is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
  • M7U had an Average Return On Invested Capital over the past 3 years of 7.47%. This is in line with the industry average of 8.22%.
  • The 3 year average ROIC (7.47%) for M7U is well above the current ROIC(0.70%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -5.07%
ROE -7.06%
ROIC 0.7%
ROA(3y)3.69%
ROA(5y)4.37%
ROE(3y)6.44%
ROE(5y)8.2%
ROIC(3y)7.47%
ROIC(5y)7.55%
M7U.DE Yearly ROA, ROE, ROICM7U.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • The Operating Margin of M7U (1.22%) is worse than 61.11% of its industry peers.
  • In the last couple of years the Operating Margin of M7U has declined.
  • M7U has a better Gross Margin (63.16%) than 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of M7U has remained more or less at the same level.
Industry RankSector Rank
OM 1.22%
PM (TTM) N/A
GM 63.16%
OM growth 3Y-16.45%
OM growth 5Y-6.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.22%
GM growth 5Y0.66%
M7U.DE Yearly Profit, Operating, Gross MarginsM7U.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

6

2. M7U.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so M7U is still creating some value.
  • Compared to 1 year ago, M7U has about the same amount of shares outstanding.
  • M7U has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, M7U has an improved debt to assets ratio.
M7U.DE Yearly Shares OutstandingM7U.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
M7U.DE Yearly Total Debt VS Total AssetsM7U.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 3.68 indicates that M7U is not in any danger for bankruptcy at the moment.
  • M7U has a Altman-Z score of 3.68. This is in the better half of the industry: M7U outperforms 64.81% of its industry peers.
  • The Debt to FCF ratio of M7U is 6.81, which is on the high side as it means it would take M7U, 6.81 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 6.81, M7U perfoms like the industry average, outperforming 42.59% of the companies in the same industry.
  • A Debt/Equity ratio of 0.14 indicates that M7U is not too dependend on debt financing.
  • The Debt to Equity ratio of M7U (0.14) is better than 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 6.81
Altman-Z 3.68
ROIC/WACC0.11
WACC6.66%
M7U.DE Yearly LT Debt VS Equity VS FCFM7U.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • M7U has a Current Ratio of 3.16. This indicates that M7U is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.16, M7U belongs to the top of the industry, outperforming 90.74% of the companies in the same industry.
  • M7U has a Quick Ratio of 1.49. This is a normal value and indicates that M7U is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of M7U (1.49) is better than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 1.49
M7U.DE Yearly Current Assets VS Current LiabilitesM7U.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. M7U.DE Growth Analysis

3.1 Past

  • The earnings per share for M7U have decreased strongly by -169.33% in the last year.
  • Looking at the last year, M7U shows a very negative growth in Revenue. The Revenue has decreased by -14.11% in the last year.
  • M7U shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.57% yearly.
EPS 1Y (TTM)-169.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.97%
Revenue 1Y (TTM)-14.11%
Revenue growth 3Y-0.85%
Revenue growth 5Y9.57%
Sales Q2Q%-11.57%

3.2 Future

  • Based on estimates for the next years, M7U will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.06% on average per year.
  • M7U is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.30% yearly.
EPS Next Y-83.33%
EPS Next 2Y-1.83%
EPS Next 3Y10.06%
EPS Next 5YN/A
Revenue Next Year-11.48%
Revenue Next 2Y-2.03%
Revenue Next 3Y1.23%
Revenue Next 5Y6.3%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
M7U.DE Yearly Revenue VS EstimatesM7U.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
M7U.DE Yearly EPS VS EstimatesM7U.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

1

4. M7U.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for M7U. In the last year negative earnings were reported.
  • M7U is valuated quite expensively with a Price/Forward Earnings ratio of 28.14.
  • M7U's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.50, M7U is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 28.14
M7U.DE Price Earnings VS Forward Price EarningsM7U.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of M7U is on the same level as its industry peers.
  • 72.22% of the companies in the same industry are cheaper than M7U, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 48.75
EV/EBITDA 19.21
M7U.DE Per share dataM7U.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.83%
EPS Next 3Y10.06%

0

5. M7U.DE Dividend Analysis

5.1 Amount

  • M7U does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

M7U.DE Fundamentals: All Metrics, Ratios and Statistics

NYNOMIC AG

FRA:M7U (4/17/2026, 7:00:00 PM)

18.9

+1.15 (+6.48%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-31
Earnings (Next)05-29
Inst Owners19.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap124.17M
Revenue(TTM)96.90M
Net Income(TTM)-6.64M
Analysts83.33
Price Target19.89 (5.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.13
Dividend Growth(5Y)-3.19%
DP-13.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.8%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.14
P/S 1.28
P/FCF 48.75
P/OCF 22.24
P/B 1.32
P/tB 2.68
EV/EBITDA 19.21
EPS(TTM)-1
EYN/A
EPS(NY)0.67
Fwd EY3.55%
FCF(TTM)0.39
FCFY2.05%
OCF(TTM)0.85
OCFY4.5%
SpS14.75
BVpS14.33
TBVpS7.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -5.07%
ROE -7.06%
ROCE 1.06%
ROIC 0.7%
ROICexc 0.79%
ROICexgc 1.51%
OM 1.22%
PM (TTM) N/A
GM 63.16%
FCFM 2.63%
ROA(3y)3.69%
ROA(5y)4.37%
ROE(3y)6.44%
ROE(5y)8.2%
ROIC(3y)7.47%
ROIC(5y)7.55%
ROICexc(3y)9.51%
ROICexc(5y)9.95%
ROICexgc(3y)21.63%
ROICexgc(5y)23.74%
ROCE(3y)11.26%
ROCE(5y)11.38%
ROICexgc growth 3Y-34.01%
ROICexgc growth 5Y-22.69%
ROICexc growth 3Y-26.92%
ROICexc growth 5Y-11.28%
OM growth 3Y-16.45%
OM growth 5Y-6.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.22%
GM growth 5Y0.66%
F-Score4
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 6.81
Debt/EBITDA 2.02
Cap/Depr 55.21%
Cap/Sales 3.13%
Interest Coverage 2.82
Cash Conversion 83.52%
Profit Quality N/A
Current Ratio 3.16
Quick Ratio 1.49
Altman-Z 3.68
F-Score4
WACC6.66%
ROIC/WACC0.11
Cap/Depr(3y)106.93%
Cap/Depr(5y)82.07%
Cap/Sales(3y)4.46%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-169.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.97%
EPS Next Y-83.33%
EPS Next 2Y-1.83%
EPS Next 3Y10.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.11%
Revenue growth 3Y-0.85%
Revenue growth 5Y9.57%
Sales Q2Q%-11.57%
Revenue Next Year-11.48%
Revenue Next 2Y-2.03%
Revenue Next 3Y1.23%
Revenue Next 5Y6.3%
EBIT growth 1Y-92.11%
EBIT growth 3Y-17.16%
EBIT growth 5Y2.83%
EBIT Next Year-11.33%
EBIT Next 3Y26.55%
EBIT Next 5YN/A
FCF growth 1Y265.93%
FCF growth 3Y-38.75%
FCF growth 5Y11.02%
OCF growth 1Y321.04%
OCF growth 3Y-25%
OCF growth 5Y12.14%

NYNOMIC AG / M7U.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NYNOMIC AG (M7U.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to M7U.DE.


What is the valuation status of NYNOMIC AG (M7U.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to NYNOMIC AG (M7U.DE). This can be considered as Overvalued.


Can you provide the profitability details for NYNOMIC AG?

NYNOMIC AG (M7U.DE) has a profitability rating of 3 / 10.


Can you provide the financial health for M7U stock?

The financial health rating of NYNOMIC AG (M7U.DE) is 6 / 10.


Can you provide the dividend sustainability for M7U stock?

The dividend rating of NYNOMIC AG (M7U.DE) is 0 / 10 and the dividend payout ratio is -13.84%.